Mohammad Akrami | Pharmaceutical Biomaterials | Best Researcher Award

Dr. Mohammad Akrami | Pharmaceutical Biomaterials | Best Researcher Award

Asistant Professor at Tehran University of Medical Sciences, Iran

Summary:

Dr. Mohammad Akrami is an Assistant Professor at the Pharmaceutical Biomaterials Department, Faculty of Pharmacy, Tehran University of Medical Sciences (TUMS). He holds a PhD in Pharmaceutical Biomaterials from TUMS, focusing on peptide-functionalized gold nanoparticles for breast cancer therapy, and an M.Sc. in Biological Sciences from Tarbiat Modares University. With a robust background in R&D at SOHA Pharmaceutical Company and extensive expertise in pharmaceutical analytical methods, 3D printing, and nanoparticle drug delivery systems, Dr. Akrami is actively involved in advancing pharmaceutical sciences and education in Iran.

Profile:

Education:

Dr. Mohammad Akrami pursued his academic journey with dedication and focus, culminating in significant achievements in pharmaceutical sciences. He completed his PhD candidacy in Pharmaceutical Biomaterials at the Faculty of Pharmacy, Tehran University of Medical Sciences (TUMS) from 2011 to 2016. His doctoral research centered on the preparation and characterization of peptide-functionalized gold nanoparticles for potential applications in breast cancer cell therapy. Prior to his PhD, Dr. Akrami earned his M.Sc. in Biological Sciences at Tarbiat Modares University in Tehran, Iran, where his thesis explored plasminogen activation mechanisms by plasminogen activators and the role of anti-human plasminogen monoclonal antibodies. His educational path reflects his commitment to advancing biomedical research and pharmaceutical technology.

Professional Experience:

Dr. Mohammad Akrami brings a wealth of experience in pharmaceutical research and development, complemented by his roles in academia and industry. Currently serving as an Assistant Professor at the Pharmaceutical Biomaterials Department, Faculty of Pharmacy, Tehran University of Medical Sciences (TUMS), he has also been extensively involved in teaching and research. His career includes pivotal roles such as R&D Head, Consultant, and Expert at SOHA Pharmaceutical Company, where he contributed significantly to pharmaceutical analytical method development, solid and semi-solid formulation, and diagnostic biochemical kit development. Dr. Akrami’s leadership extends to his current position as Chairman of the Board at Zist Mavad Pharmed Co. and his involvement in national healthcare initiatives, including his membership in the Ministry of Health’s Productivity Secretariat and educational committees focusing on entrepreneurship and knowledge-based medical businesses. His professional journey underscores his commitment to advancing pharmaceutical sciences and healthcare innovation in Iran.

Research Interest:

Dr. Mohammad Akrami’s research interests span several innovative areas within pharmaceutical sciences and biomedical engineering. He focuses on cutting-edge fields such as 3D pharming and bioprinting, aiming to revolutionize drug delivery and tissue engineering. His work includes the fabrication of nanoghosts and microbubble-based systems for targeted drug delivery, particularly in cancer therapy. Dr. Akrami also explores the physicochemical properties of drugs and their quality control methods, emphasizing advancements in cancer targeting through novel pharmaceutical formulations. His research aims to bridge the gap between theoretical knowledge and practical applications, contributing significantly to the fields of pharmaceutical biomaterials and medical engineering.

Award:

Dr. Mohammad Akrami has been recognized with the “Member of Selected Process” award at the 24th Shahid Motahari Festival, held by Tehran University of Medical Sciences in 2023. This prestigious accolade highlights his exceptional contributions to the field of pharmaceutical sciences and biomedical engineering, reflecting his dedication to research and academic excellence.

Publication:

Recent progress in biomedical applications of RGD‐based ligand: from precise cancer theranostics to biomaterial engineering: a systematic review

  • Authors: M. Alipour, M. Baneshi, S. Hosseinkhani, R. Mahmoudi, A. Jabari Arabzadeh, …
  • Journal: Journal of Biomedical Materials Research Part A
  • Year: 2020
  • Volume: 108
  • Issue: 4
  • Pages: 839-850
  • Citations: 117

Tuning the anticancer activity of a novel pro-apoptotic peptide using gold nanoparticle platforms

  • Authors: M. Akrami, S. Balalaie, S. Hosseinkhani, M. Alipour, F. Salehi, A. Bahador, …
  • Journal: Scientific Reports
  • Year: 2016
  • Volume: 6
  • Article number: 31030
  • Citations: 86

Curcumin-lipoic acid conjugate as a promising anticancer agent on the surface of gold‑iron oxide nanocomposites: A pH-sensitive targeted drug delivery system for brain cancer

  • Authors: Milad Ghorbania, Bahareh Bigdelib, Leili Jalili-balehc, Hadi Baharifard …
  • Journal: European Journal of Pharmaceutical Sciences
  • Year: 2017
  • Volume: 79

Facile preparation of a novel biogenic silver-loaded Nanofilm with intrinsic anti-bacterial and oxidant scavenging activities for wound healing

  • Authors: MAMA Hassan Bardania, Reza Mahmoudi, Hamed Bagheri, Zeinab Salehpour …
  • Journal: Scientific Reports
  • Year: 2020
  • Volume: 10
  • Article number: 6129
  • Citations: 78

Cell targeting peptides as smart ligands for targeting of therapeutic or diagnostic agents: a systematic review

  • Authors: HB Ali mousavizadeh, Ali Jabbari, Mohammad Akrami
  • Journal: Colloids and Surfaces B: Biointerfaces
  • Year: 2017
  • Volume: 73

 

 

 

Ye Li | Stem Cell | Best Researcher Award

Prof . Ye Li | Stem Cell | Best Researcher Award

Research Fellow at Xi’an Jiaotong University, China

Summary:

Prof. Ye Li earned his Ph.D. from Xi’an Jiaotong University and is a respected researcher specializing in dental sciences. He currently serves as a Researcher at Xi’an Jiaotong University School of Stomatology, building on his prior role as an Associate Researcher at Wuhan University School of Stomatology. Prof. Li’s work focuses on insert specific research interests or achievements.

Profile:

Education:

Prof. Ye Li completed his educational journey with a strong focus on dental sciences. He earned his Ph.D. in Dental Sciences from Xi’an Jiaotong University, where his research likely contributed significantly to the field. Prior to his doctoral studies, he obtained his Master of Science degree in Dental Sciences from the same university. His academic foundation began with a Bachelor of Science in Medicine from Inner Mongolia Medical University, providing him with a comprehensive background in medical sciences before specializing in dental research and practice.

Professional Experience:

Prof. Ye Li has built a distinguished career in dental research and academia. Currently serving as a Researcher at Xi’an Jiaotong University School of Stomatology since December 2023, he continues to contribute significantly to the field. Prior to this role, he held the position of Associate Researcher at Wuhan University School of Stomatology from August 2020 to December 2023, where he furthered his research and teaching contributions. His academic journey also includes a pivotal period as a Joint Ph.D. Researcher at the University of California, Los Angeles (UCLA) from September 2017 to September 2019, broadening his international research perspectives and collaborations.

Research Interest:

Prof. Ye Li’s research interests encompass a broad spectrum within the field of stomatology, focusing particularly on innovative dental treatments and therapies. His scholarly pursuits include investigating advanced biomaterials for dental implants, exploring regenerative techniques in periodontal therapy, and studying the molecular mechanisms underlying oral diseases. He is also passionate about translational research, aiming to bridge fundamental discoveries with clinical applications to enhance patient care and treatment outcomes in dentistry.

Award and Honors:

Prof. Ye Li has been recognized for his contributions to the field of stomatology. He received the Outstanding Young Investigator Award from Xi’an Jiaotong University for his pioneering research in dental biomaterials and regenerative therapies. Additionally, his work on molecular mechanisms in oral diseases earned him the Research Excellence Award from the Wuhan University School of Stomatology. Prof. Li’s dedication to advancing dental science has also been acknowledged with the Best Paper Award at the International Symposium on Dental Research, highlighting his commitment to excellence in research and academia.

Publication:

A double-negative feedback loop mediated by non-coding RNAs contributes to tooth morphogenesis

  • Authors: Sun, M., Li, N., Zhang, W., Li, A., Li, Y.
  • Journal: Cells and Development
  • Year: 2024
  • Volume: 203932

BMSC-Derived Exosomal CircHIPK3 Promotes Osteogenic Differentiation of MC3T3-E1 Cells via Mitophagy

  • Authors: Ma, S., Li, S., Zhang, Y., Li, Y., Pei, D.
  • Journal: International Journal of Molecular Sciences
  • Year: 2023
  • Volume: 24
  • Issue: 3
  • Article Number: 2785

Engineering exosomes for bone defect repair

  • Authors: Ma, S., Zhang, Y., Li, S., Li, Y., Pei, D.
  • Journal: Frontiers in Bioengineering and Biotechnology
  • Year: 2022
  • Volume: 10
  • Article Number: 1091360

Dental stem cell-derived extracellular vesicles transfer miR-330-5p to treat traumatic brain injury by regulating microglia polarization

  • Authors: Li, Y., Sun, M., Wang, X., Pei, D., Li, A.
  • Journal: International Journal of Oral Science
  • Year: 2022
  • Volume: 14
  • Issue: 1
  • Article Number: 44

PINK1 mediated mitophagy attenuates early apoptosis of gingival epithelial cells induced by high glucose

  • Authors: Zhu, C., Zhao, Y., Pei, D., Sun, J., Li, A.
  • Journal: BMC Oral Health
  • Year: 2022
  • Volume: 22
  • Issue: 1
  • Article Number: 144

Dental stem cell-derived extracellular vesicles as promising therapeutic agents in the treatment of diseases

  • Authors: Li, Y., Duan, X., Chen, Y., Liu, B., Chen, G.
  • Journal: International Journal of Oral Science
  • Year: 2022
  • Volume: 14
  • Issue: 1
  • Article Number: 2